Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy

To assess the therapeutic potential and the safety of intravitreous use of a bone marrow mononuclear fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy. The study was conducted on 10 patients with Stargardt dystrophy with worse eye visual acuity ≤ 20/125. A bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotrim, Carina Costa, Vieira Messias, André M., Jorge, Rodrigo, Siqueira, Rubens Camargo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787861/
https://www.ncbi.nlm.nih.gov/pubmed/33488737
http://dx.doi.org/10.1155/2020/8828256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787861/
https://www.ncbi.nlm.nih.gov/pubmed/33488737
http://dx.doi.org/10.1155/2020/8828256

Ejemplares similares